
ABSTRACT This study aimed to explore the potential anti‐fatigue and neuromodulatory effects of Angelica dahurica essential oil (ADEO). By integrating databases such as GeneCards and PubChem, network pharmacology and molecular docking technologies preliminarily predicted 54 potential core therapeutic targets (including PIK3R1, PIK3CB and PIK3CD) for ADEO against fatigue. In the subsequent weight‐loaded forced swimming test (WL‐FST) mouse model, ADEO inhalation intervention exhibited a trend towards improving exercise endurance and ameliorating fatigue‐related physiological phenotypes. Biochemical and histological evaluations suggest that the essential oil may be involved in regulating energy metabolism (GLU, HG, LA, BUN, LDH), buffering oxidative stress (MDA, SOD), balancing monoamine neurotransmitters (DA, 5‐HT) and stabilizing the hypothalamic–pituitary–adrenal (HPA) axis, while maintaining hippocampal neuronal structure and the expression of neural plasticity markers such as BDNF to a certain extent. To initially evaluate its translational potential in humans, an electroencephalogram (EEG) observation involving 18 volunteers was conducted. However, this section constitutes only preliminary exploratory pre‐experimental data; due to the lack of a solvent blank control group and the small sample size, the suggested potential trend of cortical arousal requires highly cautious interpretation. Overall, the mechanisms and efficacy conclusions deduced in this study remain subject to multiple major limitations: it must be strongly emphasized that the network pharmacology and molecular docking results are purely in silico computational predictions. Due to the complete absence of cell‐level experimental validation targeting PIK3R1, PIK3CD and EGFR, any direct causal link between these theoretical targets and the observed in vivo physiological phenotypes should be interpreted with extreme caution. Furthermore, the human trial has an extremely small sample size and lacks rigorous controls, and systematic long‐term safety evaluations have not yet been conducted. Future comprehensive verifications relying on rigorous molecular biology experiments and large‐scale randomized controlled clinical trials are urgently needed.
This research investigated the chemical profiling, antimicrobial and antioxidant properties, and possible molecular mechanisms that explain the bioactivity of Alpinia katsumadai seed essential oil (EO). GC–MS and HS‐SPME–GC–MS analyses revealed 67 compounds, which accounted for 96.84% and 96.26% of the overall EO composition, respectively. The primary components included α‐guaiene (24.18%), p ‐but‐(1 E )‐enyl‐anisole (10.81%), Z ‐lanceol (7.27%), β‐phellandrene (6.84%), γ‐terpineol (4.09%), and geranyl propionate (3.81%). The EO demonstrated broad‐spectrum antimicrobial a against Gram‐positive bacteria ( Bacillus cereus , B. subtilis , and Micrococcus luteus ), Gram‐negative bacteria ( Escherichia coli and Helicobacter pylori ), and Candida albicans , with MIC values ranging from 1.80 to 2.00 mg/mL. DPPH and ABTS tests showed concentration‐dependent antioxidant activity with IC 50 values of 134.6 and 153.2 mg/L, respectively. Molecular docking offered mechanistic understanding of these functions by assessing key components against B. subtilis DNA gyrase B (4URM), H. pylori urease (1E9Y), and C. albicans CYP51 (5FSA). Significantly, Z ‐lanceol displayed the most advantageous and reliable interactions, possessing XP Gscores of −4.055, −5.387, and −8.303 kcal/mol, respectively. Its anticipated affinities for urease and CYP51 surpassed those of acetohydroxamic acid and fluconazole. Together, these results highlight A. katsumadai seed EO, especially Z ‐lanceol, as a valuable source of multifunctional bioactive substances with possible uses in food preservation, pharmaceuticals, and cosmetics.
ABSTRACT This research investigated the chemical profiling, antimicrobial and antioxidant properties, and possible molecular mechanisms that explain the bioactivity of Alpinia katsumadai seed essential oil (EO). GC–MS and HS‐SPME–GC–MS analyses revealed 67 compounds, which accounted for 96.84% and 96.26% of the overall EO composition, respectively. The primary components included α‐guaiene (24.18%), p ‐but‐(1 E )‐enyl‐anisole (10.81%), Z ‐lanceol (7.27%), β‐phellandrene (6.84%), γ‐terpineol (4.09%), and geranyl propionate (3.81%). The EO demonstrated broad‐spectrum antimicrobial a against Gram‐positive bacteria ( Bacillus cereus , B. subtilis , and Micrococcus luteus ), Gram‐negative bacteria ( Escherichia coli and Helicobacter pylori ), and Candida albicans , with MIC values ranging from 1.80 to 2.00 mg/mL. DPPH and ABTS tests showed concentration‐dependent antioxidant activity with IC 50 values of 134.6 and 153.2 mg/L, respectively. Molecular docking offered mechanistic understanding of these functions by assessing key components against B. subtilis DNA gyrase B (4URM), H. pylori urease (1E9Y), and C. albicans CYP51 (5FSA). Significantly, Z ‐lanceol displayed the most advantageous and reliable interactions, possessing XP Gscores of −4.055, −5.387, and −8.303 kcal/mol, respectively. Its anticipated affinities for urease and CYP51 surpassed those of acetohydroxamic acid and fluconazole. Together, these results highlight A. katsumadai seed EO, especially Z ‐lanceol, as a valuable source of multifunctional bioactive substances with possible uses in food preservation, pharmaceuticals, and cosmetics.
ABSTRACT Jasmine ( Jasminum spp.) stands as a vital ornamental and fragrant plant because of its unique smell that serves multiple purposes in flower decoration, perfume making, cosmetic products and cultural heritage. The tropical and subtropical regions cultivate three species of the genus, namely, J. sambac , J. grandiflorum and J. auriculatum, as their most important commercial plants among the almost 202 species that belong to this genus. This review integrates current evidence on genetic resources, aroma chemistry and biosynthesis, cultivation practices, postharvest management, industrial applications and value‐chain development in Jasminum , with particular emphasis on the links between genotype, floral development, volatile production and production environment. Genomic, transcriptomic and metabolomic advances have created better pathways to discover the biosynthetic routes that produce essential fragrance elements like benzyl acetate, linalool and indole. The combination of better agronomic methods, effective pest control solutions and advanced postharvest systems has resulted in higher flower production and better flower quality in jasmine. The jasmine value chain system creates economic opportunities for various businesses while supporting the economic development of rural communities. The situation shows two main challenges, which involve creating climate‐resilient systems, maintaining fragrance quality and establishing environmentally friendly production methods. The global jasmine floriculture industry needs productivity improvement through future research that combines molecular breeding with omics methods and new technologies.
ABSTRACT N6‐methyladenosine (m6A) represents the most prevalent RNA epigenetic modification in eukaryotic cells. However, its role in eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) remains poorly characterized. This study aimed to elucidate the mechanism by which m6A modification contributes to epithelial‐mesenchymal transition (EMT) in ECRSwNP. A stable IFN‐β‐induced human nasal epithelial cell (HNEpC) model was established to induce EMT. The expression of Wilms' tumour 1‐associated protein (WTAP) and the total m6A/A ratio were assessed in HNEpCs. Subsequently, methylated RNA immunoprecipitation sequencing (MeRIP‐seq) was performed to identify potential targets of WTAP. The specific interaction between WTAP and its presumed target was confirmed through RNA immunoprecipitation assays and RNA pull‐down experiments. Additionally, rescue experiments and MeRIP were conducted to elucidate the underlying mechanism. A murine model of ECRSwNP was employed to further demonstrate WTAP's role in mediating EMT in ECRSwNP. Our findings demonstrate that WTAP plays a significant role in IFN‐β‐induced inflammation of nasal epithelial cells. WTAP upregulation correlated with inflammation and EMT in ECRSwNP. Functionally, WTAP knockdown reduced the expression of EMT biomarkers in HNEpCs. Mechanistically, MeRIP‐seq identified IRF9 as a downstream target of WTAP. WTAP knockdown significantly reduced m6A modification levels on IRF9 mRNA, leading to decreased IRF9 expression. Furthermore, m6A‐methylated IRF9, mediated by WTAP, was recognized by the m6A reader protein YTHDF1, which promoted IRF9 mRNA translation and stability. Finally, decreased WTAP expression significantly inhibited inflammation and EMT in the ECRSwNP mouse model. Our findings underscore the functional role of WTAP in ECRSwNP. WTAP promotes IRF9 mRNA translation through YTHDF1 recognition, thereby facilitating α‐SMA and vimentin transcription while promoting E‐cadherin and β‐catenin degradation in both HNEpCs and the ECRSwNP mouse model.